Story

Biolight Terminates Change-in-Control Talks; Trading to Resume August 10

ENTHMSVIIDZHZH-TWJAKOHI
Aug 9, 20261 min read
Biolight Terminates Change-in-Control Talks; Trading to Resume August 10
Text size
Background

Biolight Co., Ltd. (300246.SZ) has called off a significant corporate action that could have resulted in a change of control for the company, according to a corporate filing. Trading in the company's shares and convertible bonds, which was halted earlier this month, is scheduled to resume on August 10, 2026.

Deal Termination

The company stated that its controlling shareholder had been in discussions with a counterparty regarding a potential change in corporate control. However, after a period of negotiation and due diligence, the parties have mutually decided to terminate the plans.

According to the announcement, the decision was made after "careful consideration" and taking into account various opinions. The filing cited the complexity of the deal, stating that it "involved many issues," as the reason for the termination.

Market Impact and Trading Resumption

Sample IUX Markets – In-articleAd

Investors will be watching the market's reaction as trading resumes. The termination of a major deal like a change in control often introduces uncertainty and can lead to share price volatility.

Biolight's securities have been suspended from trading for several days:

  • Initial Halt: Trading in the company's stock and its "Baolai Convertible Bonds" was suspended from the market open on August 3, 2026.
  • Halt Extension: The suspension was extended on August 5 as talks continued.
  • Resumption: Both the stock and the convertible bonds will resume trading on August 10, 2026. The conversion period for the bonds will also be reinstated.

Read next

More on Stocks
Back to latest news

LATEST